Results
1 -
10 of
126Apsel et al..
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases, Nature Chemical Biology, 2008 Sean Ekins and Antony J. Williams.
Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development, Lab Chip, 2010, 10, 13. Blair et al..
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics, Nature Chemical Biology, 2007 Elizabeth J. JoslinThese authors contributed equally to this manuscript., Harish Shankaran, Lee K. Opresko, Nikki Bollinger, Douglas A. Lauffenburger and H. Steven Wiley.
Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context, Mol. Biosyst., 2010, 6, 1293. Po-Cheng Chen, Yi-You Huang and Jyh-Lyh Juang.
MEMS microwell and microcolumn arrays: novel methods for high-throughput cell-based assays, Lab Chip, 2011, 11, 3619. Jingxian ZhangThe authors contributed equally to this work., Jia Jia, Feng Zhu, Xiaohua Ma, Bucong Han, Xiaona Wei, Chunyan Tan, Yuyang Jiang and Yuzong Chen.
Analysis of bypass signaling in EGFR pathway and profiling of bypass genes for predicting response to anticancer EGFR tyrosine kinase inhibitors, Mol. Biosyst., 2012, 8, 2645. Juswinder Singh, Erica Evans, Margit Hagel, Matthew Labinski, Alex Dubrovskiy, Mariana Nacht, Russell C. Petter, Aravind Prasad, Michael Sheets, Thia St Martin, Robert Tjin Tham Sjin, William Westlin
and Zhendong Zhu.
Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in overcoming drug resistance, Med. Chem. Commun., 2012, 3, 780. Alexander H. Stegh.
Toward personalized cancer nanomedicine – past, present, and future, Integr. Biol., 2013, 5, 48. D. Stabley, S. Retterer, S. Marshall and K. Salaita.
Manipulating the lateral diffusion of surface-anchored EGF demonstrates that receptor clustering modulates phosphorylation levels, Integr. Biol., 2013, 5, 659. Mostafa M. Hamed, Dalal A. Abou El Ella, Adam B. Keeton, Gary A. Piazza, Matthias Engel, Rolf W. Hartmann and Ashraf H. Abadi.
Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: influence of the position 4 substituent, Med. Chem. Commun., 2013, 4, 1202.